Tirzepatide 5mg KwikPen

Tirzepatide (5mg) KwikPen

Tirzepatide 5mg KwikPen is a prescription
injectable medicine containing tirzepatide. It is administered
once weekly by subcutaneous injection and may be prescribed as
part of an appropriate treatment plan for type 2 diabetes and
weight management.

• Helps improve blood glucose control in appropriate patients
  with type 2 diabetes.
• May be prescribed as part of a medically supervised weight-management
  treatment plan where approved and appropriate.
• Used together with an appropriate diet and physical activity
  program according to healthcare professional advice.

Follow the prescribed weekly schedule

• Tirzepatide 5mg is administered once weekly by subcutaneous injection.
• It may be administered at any time of day, with or without meals.
• Injection sites include the abdomen, thigh, or upper arm.
• Rotate injection sites with each dose and follow your healthcare
  professional’s instructions.

This product is supplied as a multi-dose prefilled KwikPen.

• The pen is intended for single-patient use.
• The KwikPen contains four fixed weekly doses according to the
  product instructions.
• Do not share the pen with another person, even if the needle is changed.
• Follow the supplied Instructions for Use for correct pen operation
  and disposal.

Nausea

Diarrhea

Vomiting

Constipation

Abdominal Pain

Indigestion

• Do not use tirzepatide if you have a personal or family history
  of medullary thyroid carcinoma (MTC) or Multiple Endocrine
  Neoplasia syndrome type 2 (MEN 2).
• Do not use it if you have experienced a serious hypersensitivity
  reaction to tirzepatide or its ingredients.
• Seek medical attention for severe or persistent abdominal pain,
  particularly if accompanied by vomiting.
• Nausea, vomiting and diarrhea can cause dehydration and may
  affect kidney function.
• Hypoglycemia may occur, particularly when tirzepatide is used
  together with insulin or insulin-secretagogue medicines.
• Tell your healthcare professional about all medicines you take
  before starting treatment.

What is Tirzepatide 5mg KwikPen used for?

Tirzepatide may be prescribed to improve blood glucose control in
appropriate patients with type 2 diabetes and may also be used
for medically supervised weight management where approved.

Is Tirzepatide insulin?

No. Tirzepatide is not insulin. It is a dual GIP and GLP-1 receptor
agonist that helps regulate blood glucose and appetite.

How often is Tirzepatide 5mg injected?

Tirzepatide 5mg is administered once weekly according to the
prescribed treatment schedule.

Where can Tirzepatide 5mg be injected?

The injection may be administered under the skin of the abdomen,
thigh, or upper arm. Injection sites should be rotated.

Does Tirzepatide 5mg require refrigeration?

Yes. The product should be refrigerated at 2°C to 8°C and should
not be frozen.

What are common side effects of Tirzepatide?

Common side effects include nausea, diarrhea, vomiting, constipation,
abdominal pain and indigestion.

Medical Notice

This product information is provided for educational purposes and
does not replace advice from a qualified healthcare professional.
Tirzepatide is a prescription medicine and should be used only
according to an appropriate medical prescription and treatment plan.

No return policy available for this product.

Please verify the product name, strength, quantity, device,
storage requirements and prescription requirements before
placing your order.

WellnessHealthCart